The ReWalk Robotics Ltd. (RWLK) Position Maintained by California Public Employees Retirement System

The ReWalk Robotics Ltd. (RWLK) Position Maintained by California Public Employees Retirement System

California Public Employees Retirement System held its stake in ReWalk Robotics Ltd. (NASDAQ:RWLK) during the second quarter, Holdings Channel reports. The institutional investor owned 205,000 shares of the medical device company’s stock at the end of the second quarter. California Public Employees Retirement System owned 1.66% of ReWalk Robotics worth $1,328,000 as of its most recent SEC filing.

ReWalk Robotics Ltd. (NASDAQ:RWLK) traded down 3.35% during trading on Thursday, reaching $5.77. 24,197 shares of the company were exchanged. The stock’s market capitalization is $72.02 million. The company’s 50-day moving average price is $5.89 and its 200-day moving average price is $7.39. ReWalk Robotics Ltd. has a 1-year low of $5.55 and a 1-year high of $17.40.

ReWalk Robotics (NASDAQ:RWLK) last announced its earnings results on Thursday, August 4th. The medical device company reported ($0.64) EPS for the quarter, missing analysts’ consensus estimates of ($0.53) by $0.11. The business earned $0.82 million during the quarter, compared to analyst estimates of $1.95 million. ReWalk Robotics had a negative net margin of 556.61% and a negative return on equity of 163.18%. The firm’s revenue for the quarter was up 34.4% on a year-over-year basis. On average, equities analysts forecast that ReWalk Robotics Ltd. will post ($2.34) EPS for the current year.

RWLK has been the subject of a number of analyst reports. Canaccord Genuity reiterated a “buy” rating on shares of ReWalk Robotics in a report on Sunday, August 7th. Piper Jaffray Cos. assumed coverage on shares of ReWalk Robotics in a research note on Friday, July 15th. They issued an “overweight” rating and a $10.00 price target for the company. Finally, Zacks Investment Research downgraded shares of ReWalk Robotics from a “buy” rating to a “hold” rating in a research note on Thursday, July 7th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $12.80.

In other ReWalk Robotics news, Director Wayne Weisman sold 100,000 shares of the business’s stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $6.37, for a total value of $637,000.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Scp Vitalife Partners (Israel) sold 25,038 shares of the business’s stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $6.37, for a total transaction of $159,492.06. The disclosure for this sale can be found here. 17.70% of the stock is currently owned by company insiders.

About ReWalk Robotics

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Related posts

Leave a Comment